Behind the scenes the past 10 years, the pharmaceutical industry has been going through some important changes in how it responds to the need for medicines and vaccines in developing countries.
The AIDS epidemic in many developing countries was the tipping point and set the changes in motion.
Now, the global health community faces a different, but just as challenging task: to address the mounting threats of cardiovascular diseases, diabetes, cancers, and chronic respiratory diseases (collectively called noncommunicable diseases or NCDs).